Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marciéli Fabris

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Current Pharmaceutical Design|March 31, 2023
Computational Strategies Targeting Inhibition of <i>Helicobacter pylori</i> and <i>Cryptococcus neoformans</i> UreasesMarciéli Fabris, Nailton M Nascimento-Júnior, Marcelle L F Bispo, et al.
Anti-Cancer Agents in Medicinal Chemistry|January 19, 2023
CYP1B1: A Promising Target in Cancer Drug DiscoveryMarciéli Fabris, Mariana Luiza Silva, Kaio Maciel de Santiago-Silva, et al.
Current Drug Targets|July 20, 2023
Proteasome as a Drug Target in Trypanosomatid DiseasesMariana Luiza Silva, Kaio Maciel de Santiago-Silva, Marciéli Fabris, et al.
ACS Omega|June 9, 2025
Molecular Modeling and <i>In Vitro</i> Evaluation of Thioureas and Arylthioureas as Urease InhibitorsMarciéli Fabris, Priscila G Camargo, Mariana L Silva, et al.
Chemico-Biological Interactions|July 19, 2022
Thiohydantoins and hydantoins derived from amino acids as potent urease inhibitors: Inhibitory activity and ligand-target interactionsPriscila Goes Camargo, Marciéli Fabris, Matheus Yoshimitsu Tatsuta Nakamae, et al.
Frontiers in Microbiology|March 24, 2023
Synergistic antifungal interaction of <i>N</i>-(butylcarbamothioyl) benzamide and amphotericin B against <i>Cryptococcus neoformans</i>Gabriella Maria Andriani, Lais Fernanda de Almeida Spoladori, Marciéli Fabris, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Current Pharmaceutical Design|March 31, 2023
Computational Strategies Targeting Inhibition of <i>Helicobacter pylori</i> and <i>Cryptococcus neoformans</i> UreasesMarciéli Fabris, Nailton M Nascimento-Júnior, Marcelle L F Bispo, et al.
Anti-Cancer Agents in Medicinal Chemistry|January 19, 2023
CYP1B1: A Promising Target in Cancer Drug DiscoveryMarciéli Fabris, Mariana Luiza Silva, Kaio Maciel de Santiago-Silva, et al.
Current Drug Targets|July 20, 2023
Proteasome as a Drug Target in Trypanosomatid DiseasesMariana Luiza Silva, Kaio Maciel de Santiago-Silva, Marciéli Fabris, et al.
ACS Omega|June 9, 2025
Molecular Modeling and <i>In Vitro</i> Evaluation of Thioureas and Arylthioureas as Urease InhibitorsMarciéli Fabris, Priscila G Camargo, Mariana L Silva, et al.
Chemico-Biological Interactions|July 19, 2022
Thiohydantoins and hydantoins derived from amino acids as potent urease inhibitors: Inhibitory activity and ligand-target interactionsPriscila Goes Camargo, Marciéli Fabris, Matheus Yoshimitsu Tatsuta Nakamae, et al.
Frontiers in Microbiology|March 24, 2023
Synergistic antifungal interaction of <i>N</i>-(butylcarbamothioyl) benzamide and amphotericin B against <i>Cryptococcus neoformans</i>Gabriella Maria Andriani, Lais Fernanda de Almeida Spoladori, Marciéli Fabris, et al.
Pageof 1